关注
Anshul Bhalla
Anshul Bhalla
University of Tennessee Health Science Center
在 uthsc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control
A Luu, F Syed, G Raman, A Bhalla, E Muldoon, S Hadley, E Smith, M Rao
The Journal of arthroplasty 28 (9), 1490-1498. e1, 2013
1252013
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States
MZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, ...
American Journal of Transplantation 20 (11), 3061-3071, 2020
1162020
PARP-inhibitors in BRCA-associated pancreatic cancer
A Bhalla, MW Saif
JOP. Journal of the Pancreas 15 (4), 340-343, 2014
352014
Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: one-year kidney allograft outcomes
MZ Molnar, A Azhar, M Tsujita, M Talwar, V Balaraman, A Bhalla, ...
American Journal of Kidney Diseases 77 (5), 739-747. e1, 2021
322021
Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome–a single center experience
S Kant, A Bhalla, S Alasfar, N Alachkar
BMC nephrology 21, 1-6, 2020
192020
Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation
MZ Molnar, VS Potluri, DE Schaubel, ME Sise, BP Concepcion, ...
American Journal of Transplantation 22 (2), 599-609, 2022
152022
Complement-based therapy in the management of antibody-mediated rejection
A Bhalla, N Alachkar, S Alasfar
Advances in Chronic Kidney Disease 27 (2), 138-148, 2020
122020
Utility of serial donor-derived cell-free DNA measurements for detecting allograft rejection in a kidney transplant recipient after PD-1 checkpoint inhibitor administration
L Lakhani, S Alasfar, A Bhalla, A Aala, A Rosenberg, D Ostrander, ...
Transplantation Direct 7 (2), e656, 2021
112021
Donor-derived cell-free DNA kinetics post-kidney transplant biopsy
Y Kyeso, A Bhalla, AP Smith, Y Jia, S Alakhdhair, SC Ogir, M Abuzeineh, ...
Transplantation Direct 7 (6), e703, 2021
82021
Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non‐hepatitis C‐infected donors: time to revise the kidney donor profile index–a retrospective …
M Yazawa, V Balaraman, M Tsujita, A Azhar, M Talwar, A Bhalla, ...
Transplant International 33 (12), 1732-1744, 2020
82020
Comparison of short-term outcomes in kidney transplant recipients from SARS-CoV-2–infected versus noninfected deceased donors
J Yamauchi, A Azhar, IE Hall, A Bhalla, VS Potluri, B Tanriover, G Gupta, ...
Clinical Journal of the American Society of Nephrology 18 (11), 1466-1475, 2023
62023
Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients
U Agbim, O Cseprekal, M Yazawa, M Talwar, V Balaraman, A Bhalla, ...
Renal Failure 42 (1), 767-775, 2020
42020
The incidence of cytomegalovirus infection after deceased-donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients
M Yazawa, T Fülöp, O Cseprekal, M Talwar, V Balaraman, A Bhalla, ...
Renal Failure 42 (1), 1083-1092, 2020
32020
More exams, more problems: do we really need a new accreditation system for transplant nephrology?
SS Farouk, A Bhalla, M Harhay, L Lakhani, LS Russo, S Sanoff, M Samra, ...
American journal of kidney diseases 84 (6), 663-666, 2024
12024
CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors
A Azhar, M Tsujita, M Talwar, V Balaraman, A Bhalla, JD Eason, ...
Renal Failure 44 (1), 831-841, 2022
12022
Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings
JP Kothadia, A Bhalla, MZ Molnar, R Mohan, V Balaraman, M Talwar, ...
Transplantation Direct 8 (6), e1342, 2022
12022
Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys
A Azhar, LA Binari, K Joglekar, M Tsujita, M Talwar, V Balaraman, ...
Clinical Transplantation 35 (12), e14485, 2021
12021
Validation of prognostic index for allograft outcome in kidney transplant recipients with transplant glomerulopathy
M Talwar, V Balaraman, A Bhalla, O Cseprekal, M Yazawa, PSB Podila, ...
Kidney International Reports 5 (6), 915-920, 2020
12020
Hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C negative recipients
UA Agbim, O Cseprekal, M Yazawa, M Talwar, V Balaraman, A Bhalla, ...
AMERICAN JOURNAL OF TRANSPLANTATION 20, 581-581, 2020
12020
Incidence of cytomegalovirus infection in deceased donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients: a …
M Yazawa, T Fulop, O Cseprekal, M Talwar, V Balaraman, A Bhalla, ...
AMERICAN JOURNAL OF TRANSPLANTATION 20, 826-826, 2020
12020
系统目前无法执行此操作,请稍后再试。
文章 1–20